CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity-Reference-Cited by-同舟云学术

CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity

Published:2008-08-01 Issue:8 Volume:93 Page:3215-3221
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Huber Joakim¹,Kiefer Florian W.¹,Zeyda Maximilian¹,Ludvik Bernhard¹,Silberhumer Gerd R.²,Prager Gerhard²,Zlabinger Gerhard J.³,Stulnig Thomas M.¹

Affiliation:

1. Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine, III (J.H., F.W.K., M.Z., B.L., T.M.S.), Medical University of Vienna, 1090 Vienna, Austria

2. Department of Surgery (G.R.S., G.P.), Medical University of Vienna, 1090 Vienna, Austria

3. Institute of Immunology (G.J.Z.), Medical University of Vienna, 1090 Vienna, Austria

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/93/8/3215/9055548/jcem3215.pdf

Reference41 articles.

1. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects.;Bastard;Circulation,1999

2. Through thick and thin: wasting, obesity, and TNF α.;Spiegelman;Cell,1993

3. Adipose tissue, inflammation, and cardiovascular disease.;Berg;Circ Res,2005

4. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.;Pradhan;JAMA,2001

5. The many roles of chemokines and chemokine receptors in inflammation.;Charo;N Engl J Med,2006

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additive effects of depression and obesity on neural correlates of inhibitory control;Journal of Affective Disorders;2024-10

2. The Role of Chemokines in Obesity and Exercise-Induced Weight Loss;Biomolecules;2024-09-04

3. The Role of Inflammatory Mediators in the Pathogenesis of Obesity;Nutrients;2024-08-23

4. Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management;Nutrients;2024-08-20

5. A Review on in-vivo and in-vitro Models of Obesity and Obesity-Associated Co-Morbidities;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08-12